Evidence map›Paper›PMID 31270341›Full record

ArticleScientific reports2019

MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries.

C Alexandri, B Stamatopoulos, F Rothé, Y Bareche, M Devos, I Demeestere

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Research progress on the prevention and treatment of chemotherapy-induced ovarian damage.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  12. Article
  13. Review
  14. A Journey to Reach the Ovary Using Next-Generation Technologies.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C AlexandriResearch Laboratory in Human Reproduction, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium. Chrysanthi.Alexandri@ulb.ac.be.
B StamatopoulosLaboratory of Clinical Cell Therapy, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium.
F RothéBreast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Y BarecheBreast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID http://orcid.org/0000-0002-7208-6494
M DevosResearch Laboratory in Human Reproduction, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium.
I DemeestereResearch Laboratory in Human Reproduction, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Université Libre de Bruxelles · BE

Funding

REGULATION OF ALBUMIN GENE EXPRESSION BY SERUM COLLOIDSF05TW004621 · FIC · YESHIVA UNIVERSITY · PI PIETRANGELO, ANTONELLO · 1991 to 1991
–
6 · The paper itself

Abstract

Cancer treatments as cyclophosphamide and its active metabolites are highly gonadotoxic leading to follicle apoptosis and depletion. Considering the risk of subsequent infertility, fertility preservation is recommended. Beside the germ cells and gametes cryopreservation options, ovarian pharmacological protection during treatment appears to be very attractive. Meanwhile, the advances in the field of oncology have brought microRNAs into spotlight as a potential feature of cancer treatment. Herein, we investigated miRNAs expressions in response to chemotherapy using postnatal-day-3 (PND3) mouse ovaries. Our results revealed that several miRNAs are differently expressed during chemotherapy exposure. Amongst them, let-7a was the most profoundly downregulated and targets genes involved in crucial cellular processes including apoptosis. Thus we developed a liposome-based system to deliver the let-7a mimic in whole PND3 ovaries in vitro. We showed that let-7a mimic prevented the upregulation of genes involved in cell death and reduced the chemotherapy-induced ovarian apoptosis, suggesting that it can be an interesting target to preserve ovarian function. However, its impact on subsequent follicular development has to be further elucidated in vivo using an appropriate delivery system. In this study, we demonstrated that miRNA replacement approaches can be a useful tool to reduce chemotherapy-induced ovarian damage in the future.

Indexed as

AnimalsAntineoplastic Agents, AlkylatingApoptosisBiomarkers, TumorCell ProliferationCells, CulturedCyclophosphamideFemaleGene Expression Regulation, NeoplasticHumansMiceMice, Inbred C57BLMice, Inbred CBAMicroRNAsOvarian FollicleOvaryAntineoplastic Agents, AlkylatingBiomarkers, TumorCyclophosphamideMicroRNAsmirnlet7 microRNA, mouse

Identifiers

PMID31270341
PMCPMC6610114
OpenAlexW2953498790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.